Form 4: Immunome CSO Gifts Shares, Updates Holdings

Immunome Inc.'s Chief Scientific Officer, Jack Higgins, reported a gift of 6,291 common shares, adjusting his direct beneficial ownership.

Summary

• Jack Higgins, Chief Scientific Officer of Immunome Inc., reported a change in beneficial ownership.
• On March 30, 2026, Higgins disposed of 6,291 shares of Immunome Inc. Common Stock via a gift (transaction code 'G').
• The transaction price for the disposed shares was $0.
• Following this transaction, Higgins directly beneficially owns 31,438 shares of Common Stock.
• Higgins also indirectly holds 1,000 shares each as custodian for three children, totaling 3,000 shares, but disclaims beneficial ownership of these shares.
• The shares held by the Reporting Person are subject to a lockup agreement dated December 15, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. A gift of shares by an insider is a routine personal financial transaction and does not typically signal a change in the company's operational performance or strategic direction.

Risks

• The lockup agreement on the Reporting Person's shares, entered into on December 15, 2025, could imply future selling pressure once it expires, though the expiration date is not specified.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders, providing transparency into their holdings. A gift transaction, while reducing direct insider ownership, is distinct from a market sale and often reflects personal estate planning rather than a change in sentiment about the company's prospects.

Comparison to Industry Standards

• Form 4 filings are standard regulatory disclosures across all publicly traded companies in the U.S.
• This specific transaction, a gift of shares, is a common occurrence for insiders engaging in personal financial planning, similar to transactions seen at companies like Pfizer (PFE) or Moderna (MRNA) where executives may gift shares for philanthropic or family reasons.
• The lockup agreement is also a standard feature for insiders, particularly post-IPO or secondary offerings, to manage market supply.

Related Party Transactions

• Gift of 1,000 shares each to custodial accounts for three children, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but the shares were gifted, not sold on the open market, so no direct market impact from the transaction itself. The lockup agreement could be relevant for future liquidity.

Key Dates

Recommendation

This Form 4 reports a routine gift of shares by a corporate insider for personal financial planning purposes. It does not provide new information regarding the company's operational performance, financial health, or strategic outlook that would warrant a change from a 'hold' recommendation. The transaction is neutral in its implications for the company's valuation.

Keywords

Immunome Inc., IMNM, Jack Higgins, Chief Scientific Officer, Insider Trading, Form 4, Beneficial Ownership, Stock Gift, Lockup Agreement